Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lindgren

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Lakartidningen|April 4, 1984
[Fetal diagnosis in the county of Uppsala in 1982]K H Gustavson, S Jansson, P Lindgren, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 1, 1997
Listeria monocytogenes-induced liver abscess in pregnancyP Lindgren, J C Pla, U Högberg, et al.
Pharmacoeconomics|January 6, 2000
Costs of Mini Mental State Examination-related cognitive impairmentL Jönsson, P Lindgren, A Wimo, et al.
Anticancer Research|March 4, 2000
Isolation and culture of ovarian tumour cells, cytological and cell survival evaluationM Ingvarsson, T Höckenström, P Lindgren, et al.
Archives of Oral Biology|March 13, 1999
Expression of calcitonin gene-related peptide-1 receptor mRNA in human tooth pulp and trigeminal ganglionR Uddman, J Kato, P Lindgren, et al.
Rheumatology (Oxford, England)|June 16, 2005
Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritisG Kobelt, P Lindgren, Y Lindroth, et al.
The Canadian Journal of Cardiology|November 10, 2009
Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trialM Wagner, P Lindgren, E Merikle, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2006
Costs and quality of life of patients with multiple sclerosis in EuropeG Kobelt, J Berg, P Lindgren, et al.
Clinical Therapeutics|August 27, 1999
The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov modelL Jönsson, P Lindgren, A Wimo, et al.
International Journal of Clinical Practice|July 14, 2007
Determinants of cholesterol goal attainment at 12 months in patients with hypercholesterolaemia not at consensus goal after 3 months of treatment with lipid-lowering drugsP Lindgren, F Borgström, J Stålhammar, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Lakartidningen|April 4, 1984
[Fetal diagnosis in the county of Uppsala in 1982]K H Gustavson, S Jansson, P Lindgren, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 1, 1997
Listeria monocytogenes-induced liver abscess in pregnancyP Lindgren, J C Pla, U Högberg, et al.
Pharmacoeconomics|January 6, 2000
Costs of Mini Mental State Examination-related cognitive impairmentL Jönsson, P Lindgren, A Wimo, et al.
Anticancer Research|March 4, 2000
Isolation and culture of ovarian tumour cells, cytological and cell survival evaluationM Ingvarsson, T Höckenström, P Lindgren, et al.
Archives of Oral Biology|March 13, 1999
Expression of calcitonin gene-related peptide-1 receptor mRNA in human tooth pulp and trigeminal ganglionR Uddman, J Kato, P Lindgren, et al.
Rheumatology (Oxford, England)|June 16, 2005
Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritisG Kobelt, P Lindgren, Y Lindroth, et al.
The Canadian Journal of Cardiology|November 10, 2009
Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trialM Wagner, P Lindgren, E Merikle, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2006
Costs and quality of life of patients with multiple sclerosis in EuropeG Kobelt, J Berg, P Lindgren, et al.
Clinical Therapeutics|August 27, 1999
The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov modelL Jönsson, P Lindgren, A Wimo, et al.
International Journal of Clinical Practice|July 14, 2007
Determinants of cholesterol goal attainment at 12 months in patients with hypercholesterolaemia not at consensus goal after 3 months of treatment with lipid-lowering drugsP Lindgren, F Borgström, J Stålhammar, et al.
Pageof 16